Allogeneic Serum Eye Drops for the Treatment of Severe Dry Eye in Patients With Chronic Graft-Versus-Host Disease
Authors:
- Jane-Ming LinJLJane-Ming Lin
- Wen-Lu ChenWCWen-Lu Chen
- Yi-Yu TsaiYTYi-Yu Tsai
- 1 August 2007
- journal article
- case report
- Published by Wolters Kluwer Health in Cornea
- Vol. 26 (7) , 861-863
Abstract
To describe the use of allogeneic serum eye drops to treat 2 patients with chronic graft-versus-host disease (GVHD)-induced severe ocular surface disease. Small case series. Conventional therapy failed to control the ocular symptoms of 2 patients with GVHD who presented with severe dry eye syndrome. Because autologous serum was unavailable in these cases, we used allogeneic serum eye drops as an alternate option for treating their ocular surface disease. Both donors had serologic tests performed before donation. Use of the allogeneic serum eye drops had a beneficial clinical effect, with marked attenuation of the patients' symptoms. This therapy proved to be safe during 10 months of treatment. Allogeneic serum eye drops may be a good alternative treatment for patients with severe dry eyes caused by GVHD.Keywords
This publication has 7 references indexed in Scilit:
- Autologous serum eye drops for the treatment of severe dry eye in patients with chronic graft-versus-host diseaseBone Marrow Transplantation, 2003
- GVHD dry eyes treated with autologous serum tearsBone Marrow Transplantation, 2000
- HIV-1 infection transmitted by serum droplets into the eye: a case reportAIDS, 2000
- Important Concepts for Treating Ocular Surface and Tear DisordersAmerican Journal of Ophthalmology, 1997
- Production and secretion of transforming growth factor beta (TGF-β) by the human lacrimal glandCurrent Eye Research, 1996
- Epidermal growth factor is a constant component of normal human tear fluidGraefe's Archive for Clinical and Experimental Ophthalmology, 1989
- Sjögren's syndrome. Proposed criteria for classificationArthritis & Rheumatism, 1986